BioTech

MARCH 20th – GLOBAL ECONOMIES – MARKET REVIEW

MARCH 21stWORLD MARKETS-Sharp decline in U.S. dollar lifts stocks, oil – Euro has best week against the dollar since 2011 – Oil sharply higher despite oversupply concerns – European stocks helped after Athens’ assurances – Fed Loses Patience, But Is in No Hurry – Oil Markets Brace for Another DelugeThe Fed’s lack of impatience sends markets on a wild ride, […]

STOCKS RALLY, EURO GOES WILD, DOLLAR SINKS: Here’s what you need to know (DIA, SPY, SPX, QQQ, TLT, USO, OIL, BHI, DRI, USD, DXY, BIIB)

Financial technology startups are getting funding from the very industry they hope to disrupt.Known in short as fintech, these startups are changing the way people pay, lend, and invest, threatening the long-established and entrenched financial systems. In the past couple years, fintech has increased in notoriety among financiers and investors, most notably in London and New York.From investing in growing […]

6 trades on surging biotech sector

Seymour warned that the fund sat in “overbought territory,” saying that it might soon pull back. Trader Brian Kelly agreed, adding that investors might want to take profits on biotech names next week.Some biotech names may not have exhausted their momentum, trader Guy Adami said. He believes that Celgene could move even higher, adding that Gilead and Amgen may have […]

Why the biotech rally could continue

Trading Nation: How hot can biotech get?
David Seaburg, Cowen & Co., and Ari Wald, Oppenheimer, join “Power Lunch” to discuss the biotech rally.
Biotech stocks have been on fire. The industry has risen 40 percent in the past year, and added 2.3 percent on Friday alone. This after drug giant Biogen reported positive results for a new Alzheimer’s drug, leading its […]

Wall St. rises on Nike, lower dollar; snaps three-week string of losses

(Reuters) – U.S. stocks rose on Friday, pushing the Nasdaq to a 15-year high and helping the S&P 500 snap a three-week string of losses, following a pullback in the dollar, upbeat results from Nike and further biotech gains.Recent sharp gains in the U.S. dollar .DXY have increased worries about the currency’s impact on the earnings of U.S. multinationals. S&P […]

Wall St. rises on Nike, lower dollar; Nasdaq hits 15-year high

Wall St. rises on Nike, lower dollar; Nasdaq hits 15-year highBy Caroline ValetkevitchFri Mar 20, 2015 6:48pm EDT

Share this

Email
Print
A morning commuter carries an umbrella as she passes by the New York Stock Exchange during a winter storm in New York February 2, 2015.Credit: Reuters/Brendan McDermidStocks snap 3-week losing streak5:58pm EDT n”>(Reuters) – U.S. stocks rose on Friday, pushing the Nasdaq […]

Why the massive biotech rally could continue

Trading Nation: How hot can biotech get?
David Seaburg, Cowen & Co., and Ari Wald, Oppenheimer, join “Power Lunch” to discuss the biotech rally.
Biotech stocks have been on fire. The industry has risen 40 percent in the past year, and added 2.3 percent on Friday alone. This after drug giant Biogen reported positive results for a new Alzheimer’s drug, leading its […]

Markets Rally On Weaker Dollar, With Dow Breaking Two-Week Losing Streak

(AP Photo/Richard Drew)
Thanks to the removal of just one word in a monetary policy statement and a subsequent weakening in the U.S. dollar, the equity markets have rallied over the last two-and-a-half trading sessions — and the sea of green was abundant in market action on Friday. All three indices opened for trading in positive territory and only climbed […]

Wall St up on earnings, biotech boosts Nasdaq

Recent sharp gains in the U.S. dollar <.DXY> have increased worries about the currency’s impact on the earnings of U.S. multinationals. S&P 500 earnings projections for the first quarter and for 2015 have fallen sharply since Jan. 1.Among early reporters, Nike (>> Nike Inc) jumped 3.7 percent to $101.98 as the biggest boost to the Dow after it posted a […]

Biotech stocks are looking crowded, expert says

The stock has even more upside from where it was trading Friday, around $475 per share, Yaron Werber, senior biotech analyst at Citi Investment Research, told “Power Lunch.” As the Alzheimer’s drug likely will not reach the market for years, it is important to Biogen’s long-term prospects, he said.When looking at valuations, investors need to consider that low interest rates […]